Depending on the tumor type and extent of removal, additional treatments like radiation therapy or chemotherapy may be necessary.

Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

The HBV DNA Viral Load Test measures the amount of Hepatitis B virus DNA in the blood, indicating the level of viral replication and infection severity.

The test is used to confirm active Hepatitis B infection, assess disease severity, monitor treatment response, and guide treatment decisions.

No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or recent health issues.

Results are usually available within 2 to 4 days after the test.

A high viral load indicates a higher quantity of Hepatitis B virus in the blood, suggesting more active infection and potentially greater disease severity.